TKNO Alpha Teknova, Inc.: Business Value

Official company branding of Teknova Inc (TKNO)

The confirmed price history on the Separate Enterprise Value chart is 391.70. The business resilience of Alpha Teknova, Inc. (TKNO) is ensured by strict FDA raw material validation requirements, which block customers from switching to other vendors. Stable demand for laboratory consumables minimizes the impact of seasonality. Furthermore, Alpha Teknova, Inc. (TKNO) creates custom media in collaboration with developers of gene therapies and innovative drugs.

TKNO (Alpha Teknova Inc) Total Company Value history from 11/23/2025 to 10/28/2026

TKNO (Alpha Teknova, Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price Alpha Teknova|TKNO - Price Target Chart
- market capitalization data:
Market Capitalization Teknova|TKNO - Total Company Value
- book capitalization data:
Net Asset Value per Share Teknova|TKNO - Company Book Value|Market Cap to Net Assets Ratio teknova.com|TKNO - Company Total Assets
- debt and liquidity data:
Debt to Capital Alpha Teknova, Inc.|TKNO - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio teknova.com|TKNO - Company Aggregate Debts|Debts to Net Assets Teknova|TKNO - Company Long-Term Debts|Company Current Liabilities Teknova
General company analysis:TKNO (Alpha Teknova)
Original product of Alpha Teknova

Enterprise value is calculated as the sum of market capitalization and net debt, allowing for an assessment of the total cost to acquire all assets inclusive of liabilities. Amid geopolitical pressure and rising chemical raw material costs for Alpha Teknova, Inc. (TKNO), the actual business value reflects the company's resilience to logistics disruptions and operational risks.

Competitor analysis for Alpha Teknova, Inc.

Intuitive Surgical, Inc. - Enterprise Value|Danaher Corp (DHR) - Total Company Value|BDX: Business Value|Total Company Value STE|WST (westpharma.com) - Total Enterprise Value|Total Company Value BAX|Real Price to Acquire Entire Company Masimo Corp|Stevanato - Enterprise Value|Total Enterprise Value Teleflex Corp (TFX)|MMSI - Enterprise Value|Business Value envistaco.com NVST|Enterprise Value ICUI (ICU Medical)|XRAY - Company Buyout Price|LMAT (LeMaitre) - Enterprise Value|AtriCure Medical (ATRC) - Real Price to Acquire Entire Company|STAA (STAAR Surgical Company) - Enterprise Value|Enterprise Value NAGE|Total Company Value ZimVie (ZIMV)|Total Company Value AngioDynamics Inc ANGO|Real Price to Acquire Entire Company Cerus Corp|Value Adjusted for Debt and Cash Monogram Orthopedics Inc. MGRM|Enterprise Value STSS (Sharps Tech)|INFU: Company Buyout Price|Total Company Value Utah Medical Products, Inc.|KRMD (KORU Medical) - Business Value|NYXH: Total Company Value|Company Buyout Price Microbot Medical, Inc (MBOT)|Real Price to Acquire Entire Company Pro-Dex, Inc.|Aggregate Business Value ZTEK (zentek.com)|Total Company Value Elutia|MLSS - Value Adjusted for Debt and Cash|NEXGEL, Inc - Real Price to Acquire Entire Company|RVP: Enterprise Value|HBIO (Harvard Bioscience) - Total Company Value|femasys.com (FEMY) - Real Price to Acquire Entire Company|Enterprise Value MHUA (Meihua Medical Technologies)|Total Enterprise Value POAI|Total Company Value Callan JMB Inc CJMB|Business Value Atrion Corporation Inc. ATRI|Real Price to Acquire Entire Company NeuroMetrix, Inc. (NURO)